Listar Investigación y Desarrollo por autor "Camins A."
Mostrando ítems 21-24 de 24
-
Review
The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia (2020)
Folch J.; Olloquequi J.; Ettcheto M.; Busquets O.; Sánchez-López E.; Cano A.; Espinosa-Jiménez T.; García M.L.; Beas-Zarate C.; Casadesús G.; ... (Frontiers Media S.A., 2019) -
Article
The preclinical discovery and development of opicapone for the treatment of Parkinson’s disease (2020)
Ettcheto M.; Busquets O.; Sánchez-Lopez E.; Cano A.; Manzine P.R.; Verdaguer E.; Olloquequi J.; Auladell C.; Folch J.; Camins A. (Taylor and Francis Ltd, 2020) -
Article
Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer’s disease (2020)
Camins A.; Ettcheto M.; Busquets O.; Manzine P.R.; Castro-Torres R.D.; Beas-Zarate C.; Verdaguer E.; Sureda F.X.; Bulló M.; Olloquequi J.; ... (Taylor and Francis Ltd, 2019) -
Article
Vulnerability of calbindin, calretinin and parvalbumin in a transgenic/knock-in APPswe/PS1dE9 mouse model of Alzheimer disease together with disruption of hippocampal neurogenesis (2020)
Verdaguer E.; Brox S.; Petrov D.; Olloquequi J.; Romero R.; de Lemos M.L.; Camins A.; Auladell C. (Elsevier Inc., 2015)